Ensign Peak Advisors’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-414,732
Closed -$299K 1737
2025
Q3
$299K Buy
414,732
+179,057
+76% +$811K ﹤0.01% 1573
2025
Q2
$1.19M Buy
+235,675
New +$927K ﹤0.01% 1138
2023
Q2
Sell
-37,884
Closed -$79.6K 1777
2023
Q1
$79.6K Hold
37,884
﹤0.01% 1759
2022
Q4
$83K Hold
37,884
﹤0.01% 1770
2022
Q3
$114K Hold
37,884
﹤0.01% 2057
2022
Q2
$107K Hold
37,884
﹤0.01% 1949
2022
Q1
$203K Hold
37,884
﹤0.01% 1874
2021
Q4
$283K Hold
37,884
﹤0.01% 1835
2021
Q3
$344K Hold
37,884
﹤0.01% 1694
2021
Q2
$185K Hold
37,884
﹤0.01% 1733
2021
Q1
$169K Hold
37,884
﹤0.01% 1746
2020
Q4
$147K Hold
37,884
﹤0.01% 1750
2020
Q3
$122K Hold
37,884
﹤0.01% 1698
2020
Q2
$168K Hold
37,884
﹤0.01% 1598
2020
Q1
$106K Hold
37,884
﹤0.01% 1576
2019
Q4
$158K Buy
+37,884
New +$146K ﹤0.01% 1628

Other funds holding ATYR